📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors. (2021)

First Author: Lucas SCC

Attributed to: Accelerated Discovery and Development of New Medicines: Prosperity Partnership for a Healthier Nation funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.1c00344

PubMed Identifier: 34260229

Publication URI: http://europepmc.org/abstract/MED/34260229

Type: Journal Article/Review

Volume: 64

Parent Publication: Journal of medicinal chemistry

Issue: 15

ISSN: 0022-2623